Research analysts at StockNews.com initiated coverage on shares of Galmed Pharmaceuticals (NASDAQ:GLMD – Get Free Report) in a research report issued to clients and investors on Thursday. The firm set a “sell” rating on the biopharmaceutical company’s stock. Galmed Pharmaceuticals Stock Performance GLMD remained flat at $0.39 during trading on Thursday. The company had a […]
StockNews.com started coverage on shares of Galmed Pharmaceuticals (NASDAQ:GLMD – Free Report) in a report issued on Wednesday. The firm issued a sell rating on the biopharmaceutical company’s stock. Galmed Pharmaceuticals Stock Performance NASDAQ GLMD opened at $0.39 on Wednesday. Galmed Pharmaceuticals has a one year low of $0.26 and a one year high of […]
Equities research analysts at StockNews.com assumed coverage on shares of Galmed Pharmaceuticals (NASDAQ:GLMD – Get Free Report) in a research note issued on Saturday. The firm set a “sell” rating on the biopharmaceutical company’s stock. Galmed Pharmaceuticals Trading Down 1.6 % Shares of GLMD opened at $0.31 on Friday. Galmed Pharmaceuticals has a 12 month […]
StockNews.com started coverage on shares of Galmed Pharmaceuticals (NASDAQ:GLMD – Free Report) in a research note released on Tuesday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Galmed Pharmaceuticals Price Performance NASDAQ:GLMD opened at $0.36 on Tuesday. The company’s 50 day moving average price is $0.40 and its 200-day moving average […]
Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD – Get Free Report) was the recipient of a large decline in short interest in January. As of January 31st, there was short interest totalling 11,500 shares, a decline of 79.1% from the January 15th total of 55,100 shares. Based on an average daily volume of 185,500 shares, the short-interest ratio […]